Related Experiment Video
Updated: Apr 17, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.7K
[Tiotropium in asthma--a new opportunity?]
Pneumologia (Bucharest, Romania)
|February 11, 2015
Summary
Tiotropium is now an established asthma medication. This review analyzes its benefits and limitations for asthma-COPD overlap syndrome and moderate-to-severe asthma.
Area of Science:
- Pulmonology
- Pharmacology
Context:
- Tiotropium, initially studied for chronic obstructive pulmonary disease (COPD), has gained acceptance in asthma management.
- Recent indications in 2014 highlight its role in specific asthma patient groups.
Purpose:
- To review the efficacy and safety of tiotropium in asthma treatment.
- To evaluate the evidence supporting tiotropium's use in asthma-COPD overlap syndrome (ACOS).
- To assess tiotropium's role in moderate and severe asthma management.
Summary:
- Analysis of existing studies reveals both benefits and limitations of tiotropium in asthma.
- Evidence supports tiotropium's utility in ACOS, addressing a complex respiratory condition.
- Tiotropium demonstrates potential in managing moderate and severe asthma, offering a new therapeutic option.
Impact:
- Provides clinicians with a comprehensive overview of tiotropium's place in asthma guidelines.
- Informs treatment decisions for patients with ACOS and moderate-to-severe asthma.
- Contributes to the evolving understanding of long-acting muscarinic antagonist therapy in respiratory diseases.
Related Concept Videos
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
2.2K
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
2.2K
01:24Antiasthma Drugs: Methylxanthines
2.1K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
2.1K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
2.1K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
2.1K
01:24Cholinergic Antagonists: Pharmacokinetics
1.1K
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
1.1K
01:30Asthma-IV: Diagnostic and Management
3.4K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.4K
01:26COPD: Management Using Bronchodilators and Corticosteroids
1.2K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K